Finland's Optomed Q2 revenue misses estimates on lower device sales; cost cuts help EBITA loss narrow
Finland's Optomed Q2 revenue misses estimates on lower device sales; cost cuts help EBITA loss narrow
Overview
Finland medical device maker's Q2 revenue fell 8.6%, missing analyst expectations
EBITDA loss narrowed as gross margin expanded and costs declined
Company maintains 2026 outlook for revenue growth over 2025
Outlook
Optomed expects full-year 2026 revenue to grow compared to 2025
Company says a USD 2.1 mln U.S. order is expected to benefit Devices segment in H2
Company maintains focus on recurring revenue growth and cost management for H2 2026
Result Drivers
LOWER DEVICE SALES - Co said revenue decline was mainly due to lower traditional device sales
RECURRING AI REVENUE - Increased share of recurring AI-related revenue and Aurora AEYE deployments in the US supported gross margin and improved revenue mix
COST MANAGEMENT - Improved gross margin and reduced EBITDA loss attributed to higher share of recurring revenue and disciplined operating expense management
Company press release: ID:nWkr3YVkz7
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | EUR 3.52 mln | EUR 3.87 mln (3 Analysts) |
Q2 Loss Per Share |
| EUR 0.05 |
|
Q2 Net Loss |
| EUR 935,000 |
|
Q2 EBITDA |
| -EUR 457,000 |
|
Q2 EBITDA Margin |
| -13.00% |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Optomed Oyj is €2.00, about 17.4% above its August 13 closing price of €1.70
Reuters Recommended Reads
Aug 13 - Finland's Bioretec H1 revenue rises 12%, loss narrows
Aug 13 - Sensus Healthcare Q2 revenue misses estimates as unit sales fall
Aug 14 - Germany's Stratec H1 revenue falls on service parts, consumables segment decline
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)